Locations
England, UK · Oxford, UK · Oxfordshire, UK
industry
Data and Analytics · DeepTech · Hardware · Health · Software
Size
51-200 employees
Stage
Series B
founded in
2017
Ultromics is a pioneering company in the field of echocardiography, utilizing advanced AI technology to enhance diagnostic accuracy for heart failure and cardiac amyloidosis. Their flagship product, Echo Go®, is the first diagnostic support tool specifically designed for HFp EF detection, processing over 430,000 cases globally. With a strong foundation in scientific research and partnerships with leading medical institutions, Ultromics has established itself as a leader in cardiac diagnostics, achieving FDA clearance for its innovative algorithms and demonstrating significant clinical outcomes. The company aims to redefine heart failure detection, making it more accessible and efficient for healthcare providers, ultimately improving patient care and outcomes.
Something looks off?